Abivax reports promising rheumatoid arthritis results
Treatment demonstrated a good safety profile in the overall patient population during the 12-week induction phase
Read More
Tag: Abivax
Abivax’s ABX464 shows ‘impressive’ efficacy in severe ulcerative colitis patients
Once-daily oral treatment was well-tolerated and demonstrated a good safety profile in Phase IIb study
Read More
